SCHEMBL4979121

SCHEMBL4979121

CCCCCC/C=C\CCCCCCCC(=O)OCC1CO1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 2/20 0.61
DGKA P23743 1/20 0.53
LPAR3 Q9UBY5 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21582226 1.00 LPAR1 (0.61) LPAR1DGKALPAR3
SCHEMBL471851 1.00 LPAR1 (0.61) LPAR1DGKALPAR3
SCHEMBL258047 1.00 LPAR1 (0.61) LPAR1DGKALPAR3
SCHEMBL30864381 1.00 LPAR1 (0.61) LPAR1DGKALPAR3
Methane SCHEMBL11454502 0.99 LPAR1 (0.60) LPAR1DGKALPAR3
SCHEMBL29269177 0.97 LPAR1 (0.58) LPAR1DGKA
SCHEMBL29269176 0.97 LPAR1 (0.58) LPAR1DGKA
SCHEMBL23391365 0.96 LPAR1 (0.57) LPAR1
SCHEMBL1374046 0.96 LPAR1 (0.57) LPAR1
SCHEMBL28659546 0.93 LPAR1 (0.53) LPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120058967-A Active peptide, stem cell exosome and application thereof in improving skin aging 广州晶捷生物科技有限公司 2025-05-30 CN claimed
CN-118240238-A Preparation method of lignin type carrier with enzyme response and nano particles thereof 大连理工大学 2024-06-25 CN claimed
CN-113999522-B Polyamide composite material and preparation method and application thereof 上海金发科技发展有限公司 2024-04-02 CN claimed
WO-2023071921-A1 POLYAMIDE COMPOSITE MATERIAL, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海金发科技发展有限公司 2023-05-04 WO claimed
CN-113999522-A Polyamide composite material and preparation method and application thereof 上海金发科技发展有限公司 2022-02-01 CN claimed
CN-120058967-A Active peptide, stem cell exosome and application thereof in improving skin aging 广州晶捷生物科技有限公司 2025-05-30 CN disclosed
WO-2024262261-A1 EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF 株式会社スリーボンド 2024-12-26 WO disclosed
CN-118240238-A Preparation method of lignin type carrier with enzyme response and nano particles thereof 大连理工大学 2024-06-25 CN disclosed
CN-113999522-B Polyamide composite material and preparation method and application thereof 上海金发科技发展有限公司 2024-04-02 CN disclosed
WO-2023071921-A1 POLYAMIDE COMPOSITE MATERIAL, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海金发科技发展有限公司 2023-05-04 WO disclosed
CN-113999522-A Polyamide composite material and preparation method and application thereof 上海金发科技发展有限公司 2022-02-01 CN disclosed
US-20080076736-A1 COMPOSITIONS CONTAINING LYSOPHOSPHATIDIC ACIDS WHICH INHIBIT APOPTOSIS AND USES THEREOF SKY HIGH, LLC (US) 2008-03-27 US disclosed
EP-1024812-B1 COMPOSITIONS CONTAINING LYSOPHOSPHATIDIC ACIDS WHICH INHIBIT APOPTOSIS AND USES THEREOF SKY HIGH LLC (US) 2007-01-24 EP disclosed
US-20060063738-A1 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof SKY HIGH, LLC (US) 2006-03-23 US disclosed
US-6949528-B1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof GODDARD JOHN G 2005-09-27 US disclosed
US-6949529-B2 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof SKY HIGH, LLC (US) 2005-09-27 US disclosed
US-20030149002-A1 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof SKY HIGH, LLC. 2003-08-07 US disclosed
US-6495532-B1 PRESERVATION AND TREATMENT OF ORGANS FOR TRANSPLANTATION WITH SUCH AS 3-OLEOYL-2-METHYL-1-THIOPHOSPHATE-GLYCERIDE AND A POTENTIATING COPONENT SUCH AS POLYETHYLENE GLYCOL, A PROTEIN OR A LIPID MEMBRANE SKY HIGH, LLC 2002-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076736-A1 COMPOSITIONS CONTAINING LYSOPHOSPHATIDIC ACIDS WHICH INHIBIT APOPTOSIS AND USES THEREOF LPAR6, LPAR1, LPAR3 LPAR1 2/4885DGKA 261/4885LPAR3 3/4885
US-20060063738-A1 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof LPAR5, LPAR2, LPAR6 LPAR1 4/4885DGKA 372/4885LPAR3 5/4885
US-20030149002-A1 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof LPAR5, LPAR2, LPAR6 LPAR1 4/4885DGKA 372/4885LPAR3 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.